Shah, Tilak Upendra, et al. “Pilot Study of Aprepitant for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Phase II Randomized, Double-Blind Placebo Controlled Trial”. JOP. Journal of the Pancreas, vol. 13, no. 5, Sept. 2012, pp. 514-8, doi:10.6092/1590-8577/855.